Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Valdivieso

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
The Canadian Journal of Urology|October 27, 2015
Photoselective laser ablation of the prostate: a review of the current 2015 tissue ablation optionsCôme Tholomier, Roger Valdivieso, Pierre-Alain Hueber, et al.
Journal of Kidney Cancer and VHL|March 23, 2017
The Role of Everolimus in Renal Cell CarcinomaMalek Meskawi, Roger Valdivieso, Paolo Dell'Oglio, et al.
Urology|February 19, 2013
GreenLight XPS 180W vs HPS 120W laser therapy for benign prostate hyperplasia: a prospective comparative analysis after 200 cases in a single-center studyTal Ben-Zvi, Pierre-Alain Hueber, Daniel Liberman, et al.
World Journal of Urology|November 28, 2018
Complications and functional outcomes of high-risk patient with cardiovascular disease on antithrombotic medication treated with the 532-nm-laser photo-vaporization Greenlight XPS-180 W for benign prostate hyperplasiaMalek Meskawi, Pierre-Alain Hueber, Roger Valdivieso, et al.
Journal of Endourology|August 29, 2017
Efficacy, Safety, and Durability of 532 nm Laser Photovaporization of the Prostate with GreenLight 180 W XPS in Men with Acute Urinary RetentionRamy Goueli, Malek Meskawi, Dominique Thomas, et al.
The Canadian Journal of Urology|August 24, 2017
180W-LBO GreenLight XPS laser vaporization for benign prostatic hyperplasia: our experience with current markers of surgical proficiency for durable and reproducible outcomesJoris Zhou, Côme Tholomier, Marc Zanaty, et al.
World Journal of Urology|June 26, 2015
Prostatitis, other genitourinary infections and prostate cancer: results from a population-based case-control studyKatharina Boehm, Roger Valdivieso, Malek Meskawi, et al.
World Journal of Urology|June 7, 2015
Comparison of renal function detriments after local tumor ablation or partial nephrectomy for renal cell carcinomaAlessandro Larcher, Malek Meskawi, Roger Valdivieso, et al.
BJU International|March 24, 2018
Multicentre international experience of 532-nm laser photoselective vaporization with GreenLight XPS in men with very large prostatesRoger Valdivieso, Pierre-Alain Hueber, Malek Meskawi, et al.
World Journal of Urology|April 10, 2015
Patterns of use and patient characteristics: brachytherapy for localized prostate cancer in octo- and nonagenariansRoger Valdivieso, Katharina Boehm, Malek Meskawi, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
The Canadian Journal of Urology|October 27, 2015
Photoselective laser ablation of the prostate: a review of the current 2015 tissue ablation optionsCôme Tholomier, Roger Valdivieso, Pierre-Alain Hueber, et al.
Journal of Kidney Cancer and VHL|March 23, 2017
The Role of Everolimus in Renal Cell CarcinomaMalek Meskawi, Roger Valdivieso, Paolo Dell'Oglio, et al.
Urology|February 19, 2013
GreenLight XPS 180W vs HPS 120W laser therapy for benign prostate hyperplasia: a prospective comparative analysis after 200 cases in a single-center studyTal Ben-Zvi, Pierre-Alain Hueber, Daniel Liberman, et al.
World Journal of Urology|November 28, 2018
Complications and functional outcomes of high-risk patient with cardiovascular disease on antithrombotic medication treated with the 532-nm-laser photo-vaporization Greenlight XPS-180 W for benign prostate hyperplasiaMalek Meskawi, Pierre-Alain Hueber, Roger Valdivieso, et al.
Journal of Endourology|August 29, 2017
Efficacy, Safety, and Durability of 532 nm Laser Photovaporization of the Prostate with GreenLight 180 W XPS in Men with Acute Urinary RetentionRamy Goueli, Malek Meskawi, Dominique Thomas, et al.
The Canadian Journal of Urology|August 24, 2017
180W-LBO GreenLight XPS laser vaporization for benign prostatic hyperplasia: our experience with current markers of surgical proficiency for durable and reproducible outcomesJoris Zhou, Côme Tholomier, Marc Zanaty, et al.
World Journal of Urology|June 26, 2015
Prostatitis, other genitourinary infections and prostate cancer: results from a population-based case-control studyKatharina Boehm, Roger Valdivieso, Malek Meskawi, et al.
World Journal of Urology|June 7, 2015
Comparison of renal function detriments after local tumor ablation or partial nephrectomy for renal cell carcinomaAlessandro Larcher, Malek Meskawi, Roger Valdivieso, et al.
BJU International|March 24, 2018
Multicentre international experience of 532-nm laser photoselective vaporization with GreenLight XPS in men with very large prostatesRoger Valdivieso, Pierre-Alain Hueber, Malek Meskawi, et al.
World Journal of Urology|April 10, 2015
Patterns of use and patient characteristics: brachytherapy for localized prostate cancer in octo- and nonagenariansRoger Valdivieso, Katharina Boehm, Malek Meskawi, et al.
Pageof 3